Miller Fisher Syndrome in a Healthy Male with Positive ANA: A Rare Presentation and Successful Outcome with IVIG Therapy

Main Article Content

Nor Fadhilah Mohamad
Ng Yu Siang

Abstract

A 29-years-old man presented with a sudden onset of double vision, oscillopsia, headache and vomiting, four days after recovering from an upper respiratory tract infection. Examination revealed bilateral painful ophthalmoplegia, ataxia, areflexia and loss of sensation over the left upper and middle thirds of his face. Neuroimaging was normal, and lumbar puncture showed albuminocytological dissociation. GQ1B and anti-nuclear antibody tests were positive. The patient’s symptoms improved after completion of intravenous immunoglobulin, with no residual neurological deficit after three months.

Downloads

Download data is not yet available.

Article Details

How to Cite
Mohamad, N. F., & Ng Yu Siang. (2025). Miller Fisher Syndrome in a Healthy Male with Positive ANA: A Rare Presentation and Successful Outcome with IVIG Therapy. Malaysian Journal of Medicine and Health Sciences, 21(6), 1371.1 – 1371.3. https://doi.org/10.47836/mjmhs.v21.i6.1371
Section
Case Report

References

Noioso CM, Bevilacqua L, Acerra GM, Della Valle P, Serio M, Vinciguerra C, et al. Miller Fisher syndrome: an updated narrative review. Frontiers in Neurology. 2023;14:1250774. DOI: 10.3389/fneur.2023.1250774.

Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher syndrome. Neurology. 2001;56(8):1104-6. DOI: 10.1212/WNL.56.8.1104.

Hess DC, Awad E, Posas H, Sethi KD, Adams R. Miller Fisher syndrome in systemic lupus erythematosus. The Journal of Rheumatology. 1990;17(11):1520-2.

Bingisser R, Speich R, Fontana A, Gmür J, Vogel B, Landis T. Lupus erythematosus and Miller-Fisher syndrome. Archives of neurology. 1994;51(8):828-30. DOI: 10.1001/archneur.1994.00540200108024.

Didier K, Bolko L, Giusti D, Toquet S, Robbins A, Antonicelli F, et al. Autoantibodies associated with connective tissue diseases: what meaning for clinicians? Frontiers in immunology. 2018;9:351512. DOI: 10.3389/fimmu.2018.00541.